Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07245784

Radicle Clarity™ RBB: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

Radicle Clarity™ RBB: A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
850 (estimated)
Sponsor
Radicle Science · Industry
Sex
All
Age
21 Years – 105 Years
Healthy volunteers
Accepted

Summary

A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

Detailed description

This is a randomized, double-blind, placebo-controlled study conducted with adult participants, residing in the United States. Eligible participants will (1) have the opportunity for meaningful improvement (at least 30%) in their primary health outcome and (2) express acceptance in taking a product and not knowing its formulation until the end of the study. Participants that report a known cardiac dysfunction, liver or kidney disease may be excluded. Participants that report a known contraindication or with well-established, significant safety concerns due to illness will be excluded. Heavy drinkers and those who report they are pregnant, trying to become pregnant, or breastfeeding will be excluded. Participants that report taking medications with a known contraindication or with well-established, significant safety concerns will be excluded. Self-reported data are collected electronically from eligible participants for 13 weeks. Participant reports of health indicators will be collected at baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTClarity Product Placebo ControlParticipants will use their Clarity Product Control as directed for a period of 12 weeks
DIETARY_SUPPLEMENTClarity Active Product 1Participants will use their Clarity Active Product (active ingredient: Himalayan Tartary buckwheat, a high-polyphenol non-grain fruit seed) as directed for a period of 12 weeks.

Timeline

Start date
2025-12-04
Primary completion
2026-12-04
Completion
2026-12-04
First posted
2025-11-24
Last updated
2025-12-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07245784. Inclusion in this directory is not an endorsement.